Topic: Hello and Greetings to All from a new member
Hi all.
My name is Art and I have been diagnosed last month with late stage CC. Unfortunately the primary which blocked only partially the lower Biliary branch left no noticeable symptoms until a secondary grew big enough to cause a problem for my GI Doc in a routine colonoscopy. He got suspicious and called for a CT scan which lead to the diagnosis. Unfortunately the doctors claim that there may not be symptoms until late stages occur. More on this in another topic later.
A little about myself. I'm a 64 year old Physicist living in the LA area of southern California. I am fortunate to have a great wife and two wonderful sons a daugther in law and two grand chiildren. My sister and nieces and a bevy of friends provide a constant stream of concern and help.
I have been to City of Hope, UC Irvine Chao Cancer Center and I am being treated at a local Oncology group with connections to UCLA. I have just had my second chemo which is the only course of treatment open to me. The components are Gemcitabine (Gemzar) and Cisplatin.
In the mean time tissue samples have been sent to the UCI/Harvard/MassGen study to search for structural abnormalities in the tumor genetics. A chinese study originally estimated that 8.5% of the CC sufferers have the gene type abnormality of the study. Subsequent American studies now ongoing seem to show a lower occurance rate of ~2%. The good news is anyone with this gene marker may be completely controllable with an oral administered drug. It takes 1 month for analysis of samples, 1 month to clear out toxins from chemo and then treatment can begin. The tissue type they are inspecting is an adenocarcinoma which is another selection element. The basis of the study is that this type of cancer is genetically identical to certain lung cancers that have been treated successfully with the drug of this study.
Since chances are slim for anyone to be an element of this group recognized therapies are started at once.
More on other topics where appropriate.
But again a hello to all.
Art